Atlas Trials

Study of XL999 in Patients With Acute Myeloid Leukemia (AML)

Clinical trial NCT00322673 · TERMINATED

Trial details

NCT number
NCT00322673
Sponsor
Symphony Evolution, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaAML
Start date
2006-05-01
Primary completion
2006-11-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.